Visium Asset Management Reports 5.5% New Stake In OHR Pharmaceutical Inc (OHRP)

Jacob Gottlieb thinks OHR Pharmaceutical Inc (NASDAQ:OHRP) is a good investment and has initiated a new position for his fund, Visium Asset Management. According to a recent filing with the Securities and Exchange Commission, Gottlieb and Visium have acquired 1.22 million shares, amassing 5.2% of the company’s common stock.

OHR Pharmaceutical Inc

Both Cliff Asness and Israel Englander have become fans of OHR Pharmaceutical Inc (NASDAQ:OHRP) and have initiated positions for their respective funds. Englander’s Millennium Management has acquired a little over 900,000 shares during the first quarter of 2014, as reported in the fund’s latest 13F filing. The position built by Asness during the same period for AQR Capital Management is much smaller – 13,100 shares. Geoffrey Raynor is also bullish on OHR Pharmaceutical Inc (NASDAQ:OHRP) and has acquired approximately 57,600 shares for his fund, Q Investments (Specter Holdings), according to its latest 13F filing.

Disclosure: none.

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click Here to Read Comments
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!